Skip to content
Screener

Johnson & Johnson JNJ Cumulative Cost Basis

Cumulative Cost Basis at other companies

Globus Medical logo
Globus MedicalGMED
$1.3B+9.6%
Abbott logo
AbbottABT
Stryker logo
StrykerSYK
Merit Medical Systems logo
Merit Medical SystemsMMSI
Intuitive Surgical logo
Intuitive SurgicalISRG
Penumbra logo
PenumbraPEN

Other financials

Income statement

See full
Revenue$25.3B+6.6%
Gross profit$17.3B+7.1%
Operating income$7.1B+7.4%
Net income$5.5B-0.1%
EPS (diluted)$2.27-0.9%

Balance sheet

See full
Cash & equivalents$20.4B+9.9%
Total debt$49.0B-3.4%
Total equity$85.0B+8.3%
Total assets$201.06B+4.0%

Cash flow

See full
Operating cash flow$8.6B+122%
CapEx$1.3B+26.7%
Free cash flow$7.3B+157%

Valuation

See full
Market cap$619.3B+50.7%
Enterprise value$647.91B+46.2%
P/E29.4×+11.3×
P/S6.3×+1.8×

Profitability

See full
Gross margin67.9%0.0pp
Operating margin26.5%+2.8pp
Net margin21.5%-3.5pp
FCF margin22.7%+2.2pp

Returns & leverage

See full
Return on equity25.7%-4.5pp
Debt / equity0.6×-0.1×
Current ratio1.1×+0.1×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The source filing: Johnson & Johnson’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:04 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000200406-26-000153
Line itemJune 28, 2026December 28, 2025
Inventories (Note 2)15,14414,191
Prepaid expenses and other4,8264,153
Total current assets59,77455,624
Property, plant and equipment at cost55,51854,364
Less: accumulated depreciation(31,936)(31,195)
Property, plant and equipment, net23,58223,169
Intangible assets, net (Note 3)48,22950,403
Goodwill (Note 3)48,47948,772

Item 1 — Financial statements

FAQ

What is Johnson & Johnson's cumulative cost basis?
Johnson & Johnson (JNJ) reported cumulative cost basis of $55.52B in Q2 2026.
How has Johnson & Johnson's cumulative cost basis changed year-over-year?
Johnson & Johnson's cumulative cost basis increased by 5.8% year-over-year, from $52.47B to $55.52B.
What is the long-term trend for Johnson & Johnson's cumulative cost basis?
Over 5 years (2020 to 2025), Johnson & Johnson's cumulative cost basis has grown at a 3.0% compound annual growth rate (CAGR), from $46.8B to $54.36B.

Ask your AI about Johnson & Johnson's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude